Cargando…
A narrative review and expert recommendations on the assessment of the clinical manifestations, follow-up, and management of post-OLT patients with ATTRv amyloidosis
Orthotopic liver transplantation (OLT) was the first treatment able to modify the natural course of hereditary transthyretin (ATTRv) amyloidosis, which is a rare and fatal disorder caused by the accumulation of misfolded transthyretin (TTR) variants in different organs and tissues and which leads to...
Autores principales: | Casasnovas, Carlos, Lladó, Laura, Borrachero, Cristina, Pérez-Santamaría, Patricia Valentina, Muñoz-Beamud, Francisco, Losada-López, Inés Asunción, Baliellas-Comellas, Maria Carme, González-Moreno, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467168/ https://www.ncbi.nlm.nih.gov/pubmed/37655225 http://dx.doi.org/10.1177/17562864231191590 |
Ejemplares similares
-
The Olt.
Publicado: (1964) -
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects
por: Russo, Massimo, et al.
Publicado: (2020) -
Current Evidence Supporting the Role of Immune Response in ATTRv Amyloidosis
por: Plantone, Domenico, et al.
Publicado: (2023) -
The patient journey toward a diagnosis of hereditary transthyretin (ATTRv) amyloidosis
por: Vera-Llonch, Montserrat, et al.
Publicado: (2021) -
Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis
por: Matsushita, Hiroaki, et al.
Publicado: (2022)